These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 29278992)
1. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs. Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992 [TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271 [TBL] [Abstract][Full Text] [Related]
3. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Lin CF; Wang CY; Bai CH Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria. Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362 [TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Schuler J; Dückelmann C; Beindl W; Prinz E; Michalski T; Pichler M Wien Klin Wochenschr; 2008; 120(23-24):733-41. PubMed ID: 19122984 [TBL] [Abstract][Full Text] [Related]
6. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study. Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of drug-drug interactions in hospitalized dermatology patients. Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital. Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276 [TBL] [Abstract][Full Text] [Related]
9. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Straubhaar B; Krähenbühl S; Schlienger RG Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536 [TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care. Gören Z; J Demirkapu M; Akpinar Acet G; Çali S; Gülçebi Idriz Oğlu M Turk J Med Sci; 2017 Feb; 47(1):47-54. PubMed ID: 28263519 [TBL] [Abstract][Full Text] [Related]
11. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine. Schrecker J; Puet B; Hild C; Schwope DM Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669 [TBL] [Abstract][Full Text] [Related]
12. Clinically relevant drug-drug interactions among elderly people with dementia. Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921 [TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions in a cohort of hospitalized elderly patients. Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients. Al-Ramahi R; Raddad AR; Rashed AO; Bsharat A; Abu-Ghazaleh D; Yasin E; Shehab O BMC Nephrol; 2016 Jul; 17():96. PubMed ID: 27456700 [TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions. Crescioli G; Brilli V; Lanzi C; Burgalassi A; Ieri A; Bonaiuti R; Romano E; Innocenti R; Mannaioni G; Vannacci A; Lombardi N Intern Emerg Med; 2021 Apr; 16(3):697-710. PubMed ID: 33355896 [TBL] [Abstract][Full Text] [Related]
16. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients. Georgiev KD; Hvarchanova N; Georgieva M; Kanazirev B Int J Clin Pharm; 2019 Dec; 41(6):1555-1561. PubMed ID: 31595450 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
18. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system. Toivo TM; Mikkola JA; Laine K; Airaksinen M Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study. Pasina L; Astuto S; Cortesi L; Tettamanti M; Franchi C; Marengoni A; Mannucci PM; Nobili A; Drugs Aging; 2016 Sep; 33(9):647-54. PubMed ID: 27581548 [TBL] [Abstract][Full Text] [Related]
20. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Johnell K; Klarin I Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]